Tci Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tci Co Ltd with three other
companies in this sector in Taiwan:
Grape King Bio Ltd
sales of 9.18 billion Taiwanese Dollars [US$298.00 million]
of which 80%
was Direct Sales),
Yungshin Global Holding Corp
(7.51 billion Taiwanese Dollars [US$243.82 million]
of which 69%
was Taiwan District), and
China Chemical and Pharmaceutical Company Limited
(7.58 billion Taiwanese Dollars [US$245.98 million]
of which 67%
Tci Co Ltd reported sales of 8.10 billion Taiwanese Dollars (US$262.79 million)
December of 2018.
increase of 98.9%
versus 2017, when the company's sales were 4.07 billion Taiwanese Dollars.
Sales at Tci Co Ltd have increased during each of the previous five years
(and since 2013, sales have increased a total of 477%).
Sales of Asia saw an increase
133.8% in 2018, from
2.65 billion Taiwanese Dollars to 6.18 billion Taiwanese Dollars.